Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug–Drug Interactions <i>in Vivo</i>
Selvi Durmuş(The Netherlands Cancer Institute), Alfred H. Schinkel(Oncode Institute), Anita van Esch, Olaf van Tellingen(Dutch Cancer Society), Els Wagenaar(The Netherlands Cancer Institute), Glòria Lozano‐Mena(The Netherlands Cancer Institute)
Cited by 39
Related Papers
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884